Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Anatoly Gibel"'
Publikováno v:
Clinical Schizophrenia & Related Psychoses. 9:36-39
As women age and enter menopause, they are sometimes more susceptible than men to certain physical and mental disorders such as osteoporosis and late-onset schizophrenia. Risedronate (Actonel©) is a bisphosphonate used for the treatment of osteopeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c7f2a985eb1a480704408c66faa1610
https://doi.org/10.3371/csrp.higi.043013
https://doi.org/10.3371/csrp.higi.043013
Autor:
Anatoly Gibel, Michael S. Ritsner
Publikováno v:
Clinical Neuropharmacology. 31:204-220
Objective: Two questions were addressed in the present report: whether cognitive improvement would occur during 12-month ziprasidone treatment and whether the changes in cognitive functioning are dependent of changes in the illness-related variables.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129108ef9aa5ace5601d6155c39626e0
https://doi.org/10.1097/wnf.0b013e3181572781
https://doi.org/10.1097/wnf.0b013e3181572781
Autor:
Chanoch Miodownik, Michael S. Ritsner, Tatyana Shleifer, Anatoly Gibel, Vladimir Lerner, Ann B. Goodman, Ekateryna Kovalyonok
Publikováno v:
Clinical Neuropharmacology. 31:25-33
Objectives:Bexarotene is a synthetic retinoid used for treat-ment of neoplastic or dermatologic disorders.Based on the retinoid dysregulation hypothesis, itwas hypothesized that bexarotene augmentationwould have a beneficial effect in the antipsychot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c743976edce3315db02310a3cb91fcbf
https://doi.org/10.1097/wnf.0b013e31806450da
https://doi.org/10.1097/wnf.0b013e31806450da
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:1401-1409
Objective This is a first report from a long-term study aimed to evaluate efficacy, safety, tolerability, cognitive functioning, and quality of life outcomes during ziprasidone treatment of chronic schizophrenia patients in the “real-world”. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091407171ecb5bbdd30952a3e41229d1
https://doi.org/10.1016/j.pnpbp.2007.06.008
https://doi.org/10.1016/j.pnpbp.2007.06.008
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:1470-1477
Objective Health related quality of life (HRQL) has become an important outcome measure in the treatment of psychiatric disorders. This long-term observational study examined ziprasidone-induced improvement in satisfaction with HRQL in schizophrenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58325cc9057c462dbf4945f5b78f9905
https://doi.org/10.1016/j.pnpbp.2007.06.029
https://doi.org/10.1016/j.pnpbp.2007.06.029
Autor:
Michael S. Ritsner, Anatoly Gibel
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:1442-1452
Objective This study examined specific predictors of the efficacy of risperidone (RP), olanzapine (OL) and first-generation antipsychotic agents (FGAs), the role of confounding factors, and concomitant agents such as antidepressants, anxiolytics, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a8b2eb8081417dff85ea9ea605c8d5
https://doi.org/10.1016/j.pnpbp.2006.06.002
https://doi.org/10.1016/j.pnpbp.2006.06.002
Publikováno v:
Journal of Clinical Psychopharmacology. 26:495-499
Background: Dehydroepiandrosterone (DHEA) augmentation has been reported, in a preliminary fashion, to be useful in the management of schizophrenia symptoms and side effects. In this study, the intention was to investigate the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2264de7265e91b240434f0ea021541a
https://doi.org/10.1097/01.jcp.0000237942.50270.35
https://doi.org/10.1097/01.jcp.0000237942.50270.35
Publikováno v:
Quality of Life Research. 15:515-526
This study aimed to identify factors that influence changes in satisfaction with quality of life (QOL) of schizophrenia patients. Baseline and follow up data for 148 schizophrenia patients were obtained at hospital admission and 16 months later. Rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6567d5b4b248774024dc3eabccd4ee
https://doi.org/10.1007/s11136-005-2808-9
https://doi.org/10.1007/s11136-005-2808-9
Publikováno v:
Quality of Life Research. 14:1693-1703
We sought to identify a core subset of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) items that maintains the validity and psychometric properties of the basic version. A parsimonious subset of items from the Q-LES-Q that can acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79acfe7bedbcc8637693b48e4099ab4d
https://doi.org/10.1007/s11136-005-2816-9
https://doi.org/10.1007/s11136-005-2816-9
Publikováno v:
Psychiatry Research. 136:173-179
We sought to examine stability associations between family history and variability of schizophrenia symptoms repeatedly examined during a naturalistic follow-up study. The Positive and Negative Syndrome Scale, the Insight and Treatment Attitudes Ques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb63d52c6b7ade2f65befc49f4f9ac6
https://doi.org/10.1016/j.psychres.2005.04.006
https://doi.org/10.1016/j.psychres.2005.04.006